{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T06:54:48Z","timestamp":1776927288232,"version":"3.51.2"},"reference-count":36,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Department of Science and Technology of Sichuan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","award":["21HXFH011"],"award-info":[{"award-number":["21HXFH011"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","award":["ZYJC18018"],"award-info":[{"award-number":["ZYJC18018"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019014","name":"Chengdu Science and Technology Program","doi-asserted-by":"publisher","award":["2019-YF05-01082-SN"],"award-info":[{"award-number":["2019-YF05-01082-SN"]}],"id":[{"id":"10.13039\/501100019014","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2022YFQ0003"],"award-info":[{"award-number":["2022YFQ0003"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.clbc.2022.08.013","type":"journal-article","created":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T12:10:51Z","timestamp":1662034251000},"page":"771-780","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Geriatric Early-Stage Triple-Negative Breast Cancer Patients in Low-risk Population: Omitting Chemotherapy Based on Nomogram"],"prefix":"10.1016","volume":"22","author":[{"given":"Chen","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenggui","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2022.08.013_bib0001","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s10549-012-2315-y","article-title":"Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up","volume":"136","author":"Malorni","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2022.08.013_bib0002","doi-asserted-by":"crossref","first-page":"691","DOI":"10.6004\/jnccn.2022.0030","article-title":"Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology","volume":"20","author":"Gradishar","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.clbc.2022.08.013_bib0003","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0140-6736(11)61625-5","article-title":"Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100\u2008000 women in 123 randomised trials","volume":"379","year":"2012","journal-title":"The Lancet"},{"key":"10.1016\/j.clbc.2022.08.013_bib0004","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejso.2020.09.022","article-title":"The influence of age, comorbidity and frailty on treatment with surgery and systemic therapy in older women with operable triple negative breast cancer (TNBC) in England: a population-based cohort study","volume":"47","author":"Jauhari","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2022.08.013_bib0005","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000346834","article-title":"Side effects of standard adjuvant and neoadjuvant chemotherapy regimens according to age groups in primary breast cancer","volume":"8","author":"Reinisch","year":"2013","journal-title":"Breast Care (Basel)"},{"key":"10.1016\/j.clbc.2022.08.013_bib0006","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.breast.2013.01.009","article-title":"Triple negative breast cancer: clinical characteristics in the different histological subtypes","volume":"22","author":"Dreyer","year":"2013","journal-title":"The Breast"},{"issue":"9","key":"10.1016\/j.clbc.2022.08.013_bib0008","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.6004\/jnccn.2021.0043","article-title":"NCCN Guidelines\u00ae Insights: Older Adult Oncology, Version 1.2021","volume":"19","author":"Dotan","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.clbc.2022.08.013_bib0009","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1001\/jamacardio.2016.3841","article-title":"A population-based study of cardiovascular mortality following early-stage breast cancer","volume":"2","author":"Abdel-Qadir","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.clbc.2022.08.013_bib0010","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1200\/JCO.2007.10.9710","article-title":"Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the cancer and leukemia group b experience","volume":"25","author":"Muss","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2022.08.013_bib0011","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jcmg.2018.05.012","article-title":"Anthracycline therapy is associated with cardiomyocyte atrophy and preclinical manifestations of heart disease","volume":"11","author":"Ferreira de Souza","year":"2018","journal-title":"JACC Cardiovasc Imagin"},{"key":"10.1016\/j.clbc.2022.08.013_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003006","article-title":"Chemotherapy effectiveness in trial-underrepresented groups with early breast cancer: a retrospective cohort study","volume":"16","author":"Gray","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.clbc.2022.08.013_bib0013","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s10549-011-1819-1","article-title":"Impact of comorbidity on mortality: a cohort study of 62,591 Danish women diagnosed with early breast cancer, 1990-2008","volume":"131","author":"Land","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2022.08.013_bib0014","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/jnci\/djz189","article-title":"Simulation of chemotherapy effects in older breast cancer patients with high recurrence scores","volume":"112","author":"Chandler","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2022.08.013_bib0015","first-page":"1065","article-title":"Clinicopathological features and prognosis of triple-negative breast cancer: a comparison between younger (<60) and elderly (>\/=60) patients","volume":"25","author":"Qiu","year":"2016","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.clbc.2022.08.013_bib0016","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/tbj.13251","article-title":"Adjuvant treatment and survival in older women with triple negative breast cancer: a surveillance, epidemiology, and end results analysis","volume":"25","author":"Kozak","year":"2019","journal-title":"Breast J"},{"key":"10.1016\/j.clbc.2022.08.013_bib0017","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1200\/JCO.1989.7.3.355","article-title":"A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma","volume":"7","author":"Rosen","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2022.08.013_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102292","article-title":"Systemic therapy for older patients with early breast cancer","volume":"100","author":"Battisti","year":"2021","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.clbc.2022.08.013_bib0019","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10549-013-2461-x","article-title":"The prognostic impact of age in patients with triple-negative breast cancer","volume":"138","author":"Liedtke","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2022.08.013_bib0020","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/COC.0000000000000418","article-title":"Treatment patterns among women diagnosed with stage i-iii triple-negative breast cancer","volume":"41","author":"Sineshaw","year":"2018","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.clbc.2022.08.013_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196134","article-title":"The influence of marital status and race\/ethnicity on risk of mortality for triple negative breast cancer","volume":"13","author":"Parise","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.clbc.2022.08.013_bib0022","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.ajpath.2017.03.016","article-title":"The spectrum of triple-negative breast disease: high- and low-grade lesions","volume":"187","author":"Geyer","year":"2017","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clbc.2022.08.013_bib0023","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000480087","article-title":"Early breast cancer in the elderly: characteristics, therapy, and long-term outcome","volume":"94","author":"Gal","year":"2018","journal-title":"Oncology"},{"key":"10.1016\/j.clbc.2022.08.013_bib0024","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10549-020-05776-2","article-title":"Evaluation of a beneficial effect of adjuvant chemotherapy in patients with stage I triple-negative breast cancer: a population-based study using the SEER 18 database","volume":"183","author":"Du","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2022.08.013_bib0025","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1200\/JCO.2010.32.1877","article-title":"Nodal status and clinical outcomes in a large cohort of patients with triple-negative breast cancer","volume":"29","author":"Hernandez-Aya","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2022.08.013_bib0026","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/bcr2607","article-title":"Breast cancer prognostic classification in the molecular era: the role of histological grade","volume":"12","author":"Rakha","year":"2010","journal-title":"Breast cancer research: BCR"},{"key":"10.1016\/j.clbc.2022.08.013_bib0027","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ejso.2017.11.027","article-title":"Clinicopathologic features and prognoses of different histologic types of triple-negative breast cancer: a large population-based analysis","volume":"44","author":"Zhao","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2022.08.013_bib0028","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1245\/s10434-016-5582-8","article-title":"Outcomes after mastectomy and lumpectomy in elderly patients with early-stage breast cancer","volume":"24","author":"Mogal","year":"2016","journal-title":"Annal Surg Oncol"},{"key":"10.1016\/j.clbc.2022.08.013_bib0029","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.radonc.2011.07.007","article-title":"Adjuvant chemotherapy and radiotherapy in triple-negative breast carcinoma: a prospective randomized controlled multi-center trial","volume":"100","author":"Wang","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clbc.2022.08.013_bib0030","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.21881","article-title":"Evaluation of adjuvant treatments for t1 n0 m0 triple-negative breast cancer","volume":"3","author":"Zhai","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.clbc.2022.08.013_bib0031","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1002\/cncr.31308","article-title":"Breast cancer-specific survival by age: worse outcomes for the oldest patients","volume":"124","author":"Freedman","year":"2018","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.clbc.2022.08.013_bib0032","doi-asserted-by":"crossref","first-page":"R122","DOI":"10.1186\/bcr3068","article-title":"Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at Stage II: usefulness of prognostic markers E-cadherin and Ki67","volume":"13","author":"Kashiwagi","year":"2011","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clbc.2022.08.013_bib0033","doi-asserted-by":"crossref","first-page":"271","DOI":"10.4048\/jbc.2015.18.3.271","article-title":"Evaluation of the survival benefit of different chemotherapy regimens in patients with t1-2n0 triple-negative breast cancer","volume":"18","author":"Kim","year":"2015","journal-title":"J Breast Cancer"},{"key":"10.1016\/j.clbc.2022.08.013_bib0034","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/tbj.13443","article-title":"Omission of radiation therapy following breast conservation in older (\u226570 years) women with T1-2N0 triple-negative breast cancer","volume":"25","author":"Haque","year":"2019","journal-title":"Breast J"},{"key":"10.1016\/j.clbc.2022.08.013_bib0035","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijrobp.2004.09.013","article-title":"Patient subsets with T1-T2, node-negative breast cancer at high locoregional recurrence risk after mastectomy","volume":"62","author":"Truong","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2022.08.013_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-018-5066-6","article-title":"Outcome for triple negative breast cancer in a retrospective cohort with an emphasis on response to platinum-based neoadjuvant therapy","volume":"174","author":"Walsh","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2022.08.013_bib0037","doi-asserted-by":"crossref","first-page":"e467","DOI":"10.1634\/theoncologist.2018-0010","article-title":"Impact of comorbidities and age on cause-specific mortality in postmenopausal patients with breast cancer","volume":"24","author":"Derks","year":"2019","journal-title":"Oncologist"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820922001902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820922001902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:25:12Z","timestamp":1761513912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820922001902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1526820922001902"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2022.08.013","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Geriatric Early-Stage Triple-Negative Breast Cancer Patients in Low-risk Population: Omitting Chemotherapy Based on Nomogram","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2022.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}